http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-527825-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_291d61be20a9c76704ff0be6c7ef67c5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56 |
| filingDate | 1971-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c010f0bbc7ee7c586e4f52035be1f36c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94b8e8abf2e5d2761b0c2db653c39c41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82dc2d3f9b998d0a53cdbf1d549864e |
| publicationDate | 1972-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CH-527825-A |
| titleOfInvention | Process for the production of compounds exhibiting therapeutic action |
| abstract | Salts having antirheumatic, anti-inflammatory, analgesic, antipyretic and muscle relaxant activity are prepd. by reacting a metal salt of an antirheumatic acidic pyrazolidine deriv. (pref. 4-butyl-1,2-diphenyl-, 4-butyl-1- phenyl-, 4-butyl-1,2-p-hydroxyphenyl- or 4-acetyl-butyl-3,5-pyrazolidinedione) with a mineral or organic salt of a basic cpd. having antipyretic, analgesic and muscle relaxant activity (pref. a 1-benzyl-3-(3-dimethylaminopropoxy)-1H-indazole) under conditions such that either the salt formed between the metal and the mineral or organic acid or the salt formed between the pyrazolidine and the basic cpd. separates out, the reaction being carried out under conditions of light, temp. and pH which do not adversely affect the stability of the prod. or its components. |
| priorityDate | 1970-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.